Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic Limbal Stem Cell Transplantation for Superficial Corneal Pathologies
NCT04932629Phase 1Unknown
- Sponsor
- L V Prasad Eye Institute
- Start
- Jul 2021
- Primary completion
- Dec 2021
01
Overview
Phase 1, open-label, single-arm trial in Corneal scar and corneal opacity, sponsored by L V Prasad Eye Institute. Primary endpoint: Measurement of any ocular or systemic adverse effects at Day 90. Status: unknown.
02
Conditions
Corneal scarcorneal opacity
Beyond the preview
Go deeper on NCT04932629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04932629.